GBL Backs CVC Offer to Buy Italy’s Recordati for $12 Billion

CVC has made a $12 billion offer to acquire Recordati, an Italian pharmaceutical company, with backing from GBL (a major shareholder). This represents a significant acquisition in the healthcare and pharmaceutical sector.